返回 Agenda
Session 13: Quality Assurance in Drug Development (GxPs)
Session Chair(s)
Elliott Berger, PHD, MS
President
ETB Regulatory Consulting, United States
- Good Clinical Practices
- Sponsor Responsibilities
- Investigator Responsibilities
- Institutional Review Boards
- Informed Consent
- Good Laboratory Practices
- Good Manufacturing Practices